Advanz Pharma Canada is a full-scale pharmaceutical company focused on the commercialization of innovative specialty, rare disease, and biosimilar medicines for Canadian patients. It offers commercial, market access, regulatory, and medical affairs capabilities to deliver patient-centric solutions that support health systems across Canada. The company emphasizes addressing unmet patient needs by placing patients at the center of its operations and tailoring products and services to diverse patient populations. Its portfolio includes medicines across therapeutic areas such as hepatology, gastroenterology, oncology, and rare diseases.
No recent deals for this company.